• Home
  • About Us
    • About Us
    • Leadership Team
  • Science
    • Biologics
    • Biomanufacturing
    • Pipeline
  • Investors
    • Overview
    • SEC Filings
    • Press Releases
    • Presentations
    • Corporate Governance
    • Investor Resources
      semaglutide
      • Email Alerts
      • FAQs
      • Tax Documents
  • Careers
  • Contact Us

Tivic Health to Report 2021 Fourth Quarter & Year-End Shareholder Update on Tuesday, April 19

Apr 14, 2022 | Press Releases

SAN FRANCISCO – Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”) a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that financial...

Tivic Health to Report 2021 Fourth Quarter & Year-End Shareholder Update on Tuesday, April 19

Apr 14, 2022 | Press Releases

SAN FRANCISCO – Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”) a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that financial...

Tivic Health Announces Key Executive Appointments Strengthening Leadership Team

Apr 5, 2022 | Press Releases

Veronica Cai Appointed to Chief Financial Officer; Ryan Sabia Promoted to Chief Operating Officer and Sanjay Ahuja Joined as Senior Vice President, Quality Assurance & Regulatory Affairs SAN FRANCISCO – Tivic Health® Systems, Inc., (Nasdaq: TIVC)...

Tivic Health Announces Key Executive Appointments Strengthening Leadership Team

Apr 5, 2022 | Press Releases

Veronica Cai Appointed to Chief Financial Officer; Ryan Sabia Promoted to Chief Operating Officer and Sanjay Ahuja Joined as Senior Vice President, Quality Assurance & Regulatory Affairs SAN FRANCISCO – Tivic Health® Systems, Inc., (Nasdaq: TIVC)...

Tivic Health’s ClearUP Named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine

Feb 7, 2022 | Press Releases

SAN FRANCISCO – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced that ClearUP® Sinus Pain Relief was named Best Sinus Pain Relief Solution of 2021 by Global Health...
« Older Entries
Next Entries »

Recent Posts

  • Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
  • Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
  • Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird’s National Security Conference
  • Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results
  • Valion Bio Announces Positive Safety Results From U.S. Government-Funded Entolimod Study, Paving Way For Therapeutic Efficacy Evaluation

Recent Comments

No comments to show.
©2026 Valion Bio

Privacy Policy

For ClearUP customer questions regarding warranty or other device inquiries, please reach out to customerservice@tivichealth.com.